127 related articles for article (PubMed ID: 25769648)
1. [Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes? (Study about 109 cases)].
Fekih O; Triki S; Hellara I; Neffati F; Chouchane S; Neji Gueddiche M; Fadhel Najjar M
Presse Med; 2015 May; 44(5):e185-90. PubMed ID: 25769648
[TBL] [Abstract][Full Text] [Related]
2. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.
Flekac M; Skrha J; Žídková K; Lacinová Z; Hilgertová J
Physiol Res; 2008; 57(5):717-726. PubMed ID: 17949258
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
5. The association of low-density lipoprotein cholesterol with elevated arterial stiffness in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth study.
Gourgari E; Stafford JM; D'Agostino R; Dolan LM; Lawrence JM; Marcovina S; Merjaneh L; Mottl AK; Shah AS; Dabelea D
Pediatr Diabetes; 2020 Aug; 21(5):863-870. PubMed ID: 32304144
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus.
Savu O; Serafinceanu C; Grajdeanu IV; Iosif L; Gaman L; Stoian I
J Int Med Res; 2014 Apr; 42(2):523-9. PubMed ID: 24567352
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin as a marker of cardiovascular risk in children and adolescents with type 1 diabetes.
Fekih O; Triki H; Triki S; Neffati F; Chouchane S; Guediche MN; Najjar MF
Pediatr Diabetes; 2017 May; 18(3):230-236. PubMed ID: 27111559
[TBL] [Abstract][Full Text] [Related]
8. HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes.
Obermannova B; Petruzelkova L; Sulakova T; Sumnik Z
Pediatr Diabetes; 2017 Jun; 18(4):304-310. PubMed ID: 27075550
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
Fekih O; Triki S; Rejeb J; Neffati F; Douki W; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
Endokrynol Pol; 2017; 68(1):35-41. PubMed ID: 26884296
[TBL] [Abstract][Full Text] [Related]
10. The risk of early cardiovascular disease in Lithuanian diabetic children and adolescents: a type 1 diabetes register database based study.
Dobrovolskienė R; Mockevičienė G; Urbonaitė B; Jurgevičienė N; Preikša RT; Ostrauskas R
Diabetes Res Clin Pract; 2013 Apr; 100(1):119-25. PubMed ID: 23410726
[TBL] [Abstract][Full Text] [Related]
11. [Is PON1 a factor of cardiovascular risk in type 2 diabetes?].
Triki S; Fekih O; Hellara I; Neffati F; Douki W; Ben Hamda K; Maatouk F; Najjar MF
Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):81-6. PubMed ID: 25813652
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
[TBL] [Abstract][Full Text] [Related]
14. Determinants of Cardiovascular Risk in 7000 Youth With Type 1 Diabetes in the Australasian Diabetes Data Network.
Couper JJ; Jones TW; Chee M; Barrett HL; Bergman P; Cameron F; Craig ME; Colman P; Davis EE; Donaghue KC; Fegan PG; Hamblin PS; Holmes-Walker DJ; Jefferies C; Johnson S; Mok MT; King BR; Sinnott R; Ward G; Wheeler BJ; Zimmermann A; Earnest A
J Clin Endocrinol Metab; 2021 Jan; 106(1):133-142. PubMed ID: 33120421
[TBL] [Abstract][Full Text] [Related]
15. Trends in prevalence of cardiovascular risk factors from 2002 to 2012 among youth early in the course of type 1 and type 2 diabetes. The SEARCH for Diabetes in Youth Study.
Kim G; Divers J; Fino NF; Dabelea D; Lawrence JM; Reynolds K; Bell RA; Mayer-Davis E; Crume T; Pettitt DJ; Pihoker C; Liu L
Pediatr Diabetes; 2019 Sep; 20(6):693-701. PubMed ID: 30903717
[TBL] [Abstract][Full Text] [Related]
16. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Viktorinova A; Svitekova K; Stecova A; Krizko M
Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
[TBL] [Abstract][Full Text] [Related]
17. Non-HDL-cholesterol and C-reactive protein in children and adolescents with type 1 diabetes.
Prado MM; Carrizo T; Abregú AV; Meroño T
J Pediatr Endocrinol Metab; 2017 Mar; 30(3):285-288. PubMed ID: 28222033
[TBL] [Abstract][Full Text] [Related]
18. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
[TBL] [Abstract][Full Text] [Related]
19. A case control study on HDL associated PON1 enzyme level in Northern Indian type 2 diabetes mellitus patients.
Wamique M; Ali W; Reddy DH; Vishwakarma P; Waseem M
Diabetes Metab Syndr; 2018 Nov; 12(6):843-847. PubMed ID: 29843993
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
Kerkeni M; Letaief A; Achour A; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2009 Jun; 42(9):777-82. PubMed ID: 19233152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
